Determination of Carboplatin's Optimal Plasmatic Exposure
NCT00145028
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
400
Enrollment
OTHER
Sponsor class
Conditions
Neoplasms
Interventions
DRUG:
Carboplatin
Sponsor
Institut Claudius Regaud